Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor-α

Alcoholism: Clinical and Experimental Research

Volumn 28, Issue 8 SUPPL., 2004, Pages

  Ohata, Mitsuru ^a   Suzuki, Hideaki ^a   Sakamoto, Kazuhiko ^a   Hashimoto, Kenichi ^a   Nakajima, Hisato ^a   Yamauchi, Masayoshi ^a   Hokkyo, Ken ^a   Yamada, Hisashi ^a   Toda, Gotaro ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alcohol; NF B; Peroxisome Proliferator Activated Receptor ; Pioglitazone; Tumor Necrosis Factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; BETA ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID PEROXIDASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; RETINOID X RECEPTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; 2,4 THIAZOLIDINEDIONE DERIVATIVE;

ACUTE DISEASE; ANIMAL CELL; BODY WEIGHT; CELL NUCLEUS; CONFERENCE PAPER; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HISTOPATHOLOGY; LIVER INJURY; LIVER NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETER; WESTERN BLOTTING; ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ANTAGONISM; LIVER DISEASE; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ETHANOL; FEMALE; LIPOPOLYSACCHARIDES; LIVER DISEASES; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 13844289492     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1097/01.ALC.0000134412.38510.F7     Document Type: Conference Paper

References (28)

1. 2, but not troglitazone, modulates IL-1β effects in human chondrocytes by inhibiting NF-κB and AP-1 activation pathway. FEBS Lett 501:24-30.
2. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489.
4. Dubuquoy L, Dharancy S, Nutten S, Petterson S, Auwerx J, Desreumaux P (2002) Role of peroxisome proliferator-activated receptor Γ and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360:1410-1418.
5. Enomoto N, Ikejima K, Bradford BU, Rivera C, Kono H, Brenner DA, Thurman RG (1998) Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 115:443-451.
6. Enomoto N, Takei Y, Hirose M, Konno A, Shibuya T, Matsuyama S, Suzuki S, Ikejima K, Kitamura T, Sato N (2003) Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-Γ, pioglitazone. J Pharmacol Exp Ther 306: 846-854.
7. Hotamisligil GS, Spiegelman BM (1994) Tumor necrosis factor-α: a key component of the obesity-diabetes link. Diabetes 43:1271-1278.
8. Jiang C, Ting AT, Seed B (1998) PPAR-γ agonists inhibit production of normocyte inflammatory cytokines. Nature 391:82-86.
9. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K, Evans RM (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA:7355-7359.
10. Kon K, Ikejima K, Hirose M, Yoshikawa M, Enomoto N, Kitamura T, Takei Y, Sato N (2002) Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem Biophys Res Commun 291:55-61.
11. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkinson WO, Willson TM, Kliewer SA (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR-γ). J Biol Chem 270:12953-12956.
12. Marra F, Efsen E, Romanelli RG, Caligiuri A, Pastacaldi S, Batignani G, Bonacchi A, Caporale R, Laffi G, Pinzani M, Gentilini P (2000) Ligands of peroxisome proliferator-activated receptor Γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 119:466-478.
13. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, Anania FA, Willson TM, Tsukamoto H (2000) Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Biochem 275:35715-35722.
14. Ohata M, Lin M, Satre M, Tsukamoto H (1997) Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol 272:G589-G596.
15. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
16. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-Γ is a negative regulator of macrophage activation. Nature 391:79-82.
17. Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661-1669.
18. Strassman G, Fong M, Kenney JS, Jacob CO (1992) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89:1681-1684.
19. 2 inhibits multiple steps in the NF-κB signaling pathway. Proc Natl Acad Sci USA 97:4844-4849.
20. Tanaka T, Itoh H, Doi K, Fukunaga Y, Hosoda K, Shintani M, Yamashita J, Chun T-H, Inoue M, Masatsugu K, Sawada N, Saito T, Inoue G, Nishimura H, Yoshimasa Y, Nakao K (1999) Down regulation of peroxisome proliferator-activated receptor Γ expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia 42:702-710.
21. Thieringer R, Fenyk-Melody JE, Le Grand CB, Shelton BA, Detmers PA, Somers EP, Carbin L, Moller DE, Wright SD, Berger J (2000) Activation of peroxisome proliferator-activated receptor gamma does not inhibit IL-6 or TNF-alpha responses of macrophages to lipopolysaccharide in vitro or in vivo. J Immunol 164:1046-1054.
22. Thurman RG, Bradford B, Iimuro Y, Knecht KT, Arteel GE, Yin M, Connor HD, Wall C, Raleigh JA, Frankenberg MV, Adachi Y, Forman DT, Brenner D, Kadiiska M, Mason RP (1998) The role of gut-derived bacterial toxins and free radicals in alcohol induced liver injury. J Gastroenterol Hepatol 13:S39-SS50.
23. Tontonoz P, Hu E, Graves R, Budavari A, Spigelman BM (1994) mPPAR γ 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234.
24. Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CD, Brun RP, Mueller E, Altiok S, Oppenheim H, Evans RM, Spiegelman BM (1997) Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci USA 94:237-241.
25. Tsukamoto H, Lin M, Ohata M, Giulivi C, French SW, Brittenham G (1999) Iron primes hepatic macrophages for NF κ B activation in alcoholic liver injury. Am J Physiol 277:G1240-G1250.
26. Uchimura K, Nakamura M, Enjoji M, Irie T, Sugimoto R, Muta T, Iwamoto H, Nawata H (2001) Activation of retinoic X receptor and peroxisome proliferator-activated receptor-Γ inhibits nitric oxide and tumor necrosis factor-α production in rat Kupffer cells. Hepatology 33:91-99.
27. Uesugi T, Froh M, Arteel G, Bradford BU, Thurman RG (2001) Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34:101-108.
28. Wan YJ, Morimoto M, Thurman RG, Bojes HK, French SW (1995) Expression of the peroxisome proliferator-activated receptor gene is decreased in experimental alcoholic liver disease. Life Sci 56:307-319.